Using this exceptionally representative PV-TMA material, we analyzed the prognostication capability of multiple biomarkers—p53, EGFR, p16, CIP2A, MET, Oct4, and NDFIP1—previously shown to function as prognostic markers in HNSCC (Fig. 3). Here, MET is linked to head and neck squamous cell carcinoma.